UTAH MEDICAL PRODUCTS, INC. (UTMD) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 3.18M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 3.18M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 3.18M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 3.18M | (m) | (m) |
| 2026-03-31 | 3.18M | (m) | (m) |
| 2025-09-30 | 3.20M | (m) | (m) |
| 2025-06-30 | 3.21M | (m) | (m) |
| 2025-03-31 | 3.25M | (m) | (m) |
| 2024-09-30 | 3.39M | (m) | (m) |
| 2024-06-30 | 3.48M | (m) | (m) |
| 2024-03-31 | 3.53M | (m) | (m) |
| 2023-09-30 | 3.63M | (m) | (m) |
| 2023-06-30 | 3.63M | (m) | (m) |
| 2023-03-31 | 3.63M | (m) | (m) |
| 2022-09-30 | 3.63M | (m) | (m) |
| 2022-06-30 | 3.62M | (m) | (m) |
| 2022-03-31 | 3.64M | (m) | (m) |
| 2021-09-30 | 3.65M | (m) | (m) |
| 2021-06-30 | 3.65M | (m) | (m) |
| 2021-03-31 | 3.65M | (m) | (m) |
| 2020-09-30 | 3.64M | (m) | (m) |
| 2020-06-30 | 3.64M | (m) | (m) |
| 2020-03-31 | 3.64M | (m) | (m) |
| 2019-12-31 | 3.70M | (m) | (m) |
| 2019-09-30 | 3.72M | (m) | (m) |
| 2019-06-30 | 3.72M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |